合成路线1
该中间体在本合成路线中的序号:
(II) The reaction of 6-chloro-4-oxo-1,2,3,4-tetrahydroquinoline (I) with propionic anhydride (II) or propionyl chloride (III) in pyridine gives 6-chloro-4-oxo-1-propionyl-1,2,3,4-tetrahydroquinoline (IV), which is then treated with hydroxylamine hydrochloride in refluxing pyridine.

【1】
Suzuki, Y.; Ohnishi, H.; Yamaguchi, K.; Mochida, E.; Kosuzume, H.; Hypotensive diuretic pharmaceutical compositions containing tetrahydroquinoline derivatives. DE 3129719; FR 2487196; GB 2081091 .
|
【2】
Susumi, J.; Shoichi, K.; Koichi, K.; 4-Oximino-1,2,3,4- tetrahydroquinoline Derivatives. DE 3129718; FR 2487346; GB 2092130 .
|
【3】
Suzuki, Y.; Yamaguchi, K.; Ohnishi, H.; Takada, K.; Toyonaka, Y.; Orita, Y.; Pharmacological properties of 6-chloro-1-ethylcarbonyl-4-oxyimino-1,2,3,4-tetrahydroquinoline. Drugs Exp Clin Res 1981, 7, 6, 823-832.
|
【4】
Hillier, K.; Castaner, J.; Serradell, M.N.; Blancafort, P.; M-12,285. Drugs Fut 1983, 8, 3, 204.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
35973 |
6-chloro-2,3-dihydro-4(1H)-quinolinone
|
|
C9H8ClNO |
详情 |
详情
|
(II) |
20095 |
propionic anhydride
|
123-62-6 |
C6H10O3 |
详情 | 详情
|
(III) |
15967 |
propanoyl chloride; propionyl chloride
|
79-03-8 |
C3H5ClO |
详情 | 详情
|
(IV) |
35974 |
6-chloro-1-propionyl-2,3-dihydro-4(1H)-quinolinone
|
|
C12H12ClNO2 |
详情 |
详情
|
合成路线2
该中间体在本合成路线中的序号:
(A) The reaction of cyclopentene oxide (I) with dimethylamine (II) gives 2-(dimethylamino)cyclopentanol (III), which is treated with methanesulfonyl chloride and NaH in THF to afford the corresponding methasulfonyl ester (IV). The condensation of (IV) with 3,4-dichloroaniline (V) in THF yields N,N-dimethyl-N'-(3,4-dichlorophenyl)cyclopentane-1,2-diamine (VI), which is acylated with propionic anhydride (A) and treated finally with maleic acid (B).

【1】
Szmuszkovicz, J.; N-(2-Aminocyclopentyl)acylanilides and treating depression. BE 0861351; BE 0861355; US 4156015 .
|
【2】
Szmuszkovicz, J.; Composes alcanoylanilides et leur preparation. BE 0875461 .
|
【3】
Szmuszkovicz, J.; N-(2-aminocyclopentyl)amides. BE 0867554; DE 2817112; FR 2416882; GB 1581914; JP 54106451; NL 7803442 .
|
【4】
Szmuszkovicz, J.; Anilide derivatives as antidepressants. US 4128663; US 4148913 .
|
【5】
Szmuszkovicz, J.; N-(2-Aminocyclopentyl)acylanilides and treating depression. US 4156733; US 4157398 .
|
【6】
Szmuszkovicz, J.; Kane, M.P.; von Voigtlander, P.F.; A new non-tricyclic antidepressant agent. Synthesis and activity of N-[trans-2-(dimethyamino)cyclopentyl]-N-(3,4-dichlorophenyl)propanamide and related compounds. J Med Chem 1981, 24, 10, 1230-36.
|
【7】
Owen, R.T.; Serradell, M.N.; Castaner, J.; U-48753 E. Drugs Fut 1984, 9, 11, 846.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(A) |
20095 |
propionic anhydride
|
123-62-6 |
C6H10O3 |
详情 | 详情
|
(B) |
23808 |
Fumaric acid; (E)-2-butenedioic acid
|
110-17-8 |
C4H4O4 |
详情 | 详情
|
(I) |
34274 |
(1R,5S)-6-oxabicyclo[3.1.0]hexane
|
|
C5H8O |
详情 |
详情
|
(II) |
19443 |
N-methylmethanamine; N,N-dimethylamine
|
124-40-3 |
C2H7N |
详情 | 详情
|
(III) |
34275 |
(1S,2S)-2-(dimethylamino)cyclopentanol
|
|
C7H15NO |
详情 |
详情
|
(IV) |
34276 |
N,N-dimethyl-N-((1S,2S)-2-[[methyl(dimethylene)-lambda(6)-sulfanyl]oxy]cyclopentyl)amine; (1S,2S)-N,N-dimethyl-2-[[methyl(dimethylene)-lambda(6)-sulfanyl]oxy]cyclopentanamine
|
|
C10H21NOS |
详情 |
详情
|
(V) |
23629 |
3,4-dichloroaniline
|
95-76-1 |
C6H5Cl2N |
详情 | 详情
|
(VI) |
34277 |
N-[(1S,2S)-2-(3,4-dichloroanilino)cyclopentyl]-N,N-dimethylamine; (1S,2S)-N(1)-(3,4-dichlorophenyl)-N(2),N(2)-dimethyl-1,2-cyclopentanediamine
|
|
C13H18Cl2N2 |
详情 |
详情
|
合成路线3
该中间体在本合成路线中的序号:
(A) This compound can be obtained in two different ways:
1) The acylation of 5-amino-1-beta-D-ribofuranosylimidazole-4-carboxamide (I) with propionic anhydride (A) in pyridine gives the corresponding tri-O-propionyl derivative (II), which by treatment with POCl3 and triethylamine in CHCl3 is converted into 5-amino-4-cyano-1-(2,3,5-tri-O-propionyl-beta-D-ribofuranosyl)imidazole (III). The hydrolysis of (III) with methanolic ammonia yields 5-amino-4-cyano-1-beta-D-ribofuranosylimidazole (IV), which is finally cyclized with phenylcyanamide (V) in methanolic ammonia at 180 C in a pressure vessel. This cyclization can also be performed with (III) and (V) directly, using the same procedure.
2) By reaction of 2-bromoadenosine (VI) with aniline (VII) in 2-methoxyethanol at 120 C.

【1】
Marumoto, R.; et al.; Synthesis and coronary vasodilating activity of 2-substituted adenosines. Chem Pharm Bull 1975, 23, 4, 759-774.
|
【2】
Marumoto, R.; et al. (Takeda Chemical Industries, Ltd.); 2,6-Diaminonebularine derivs.. US 3936439 .
|
【3】
Marumoto, R.; et al. (Takeda Chemical Industries, Ltd.); Production of 2,6-diaminonebularines. DE 2845435 .
|
【4】
Castaner, J.; Serradell, M.N.; Blancafort, P.; Thorpe, P.J.; CV-1808. Drugs Fut 1981, 6, 4, 222.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(A) |
20095 |
propionic anhydride
|
123-62-6 |
C6H10O3 |
详情 | 详情
|
(I) |
37427 |
5-amino-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]-1H-imidazole-4-carboxamide
|
|
C9H14N4O5 |
详情 |
详情
|
(II) |
37428 |
[(2R,3R,4R,5R)-5-[5-amino-4-(aminocarbonyl)-1H-imidazol-1-yl]-3,4-bis(propionyloxy)tetrahydro-2-furanyl]methyl propionate
|
|
C18H26N4O8 |
详情 |
详情
|
(III) |
37429 |
[(2R,3R,4R,5R)-5-(5-amino-4-cyano-1H-imidazol-1-yl)-3,4-bis(propionyloxy)tetrahydro-2-furanyl]methyl propionate
|
|
C18H24N4O7 |
详情 |
详情
|
(IV) |
37430 |
5-amino-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]-1H-imidazole-4-carbonitrile
|
|
C9H12N4O4 |
详情 |
详情
|
(V) |
37431 |
phenylcyanamide
|
|
C7H6N2 |
详情 |
详情
|
(VI) |
37432 |
(2R,3R,4S,5R)-2-(6-amino-2-bromo-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydro-3,4-furandiol
|
|
C10H12BrN5O4 |
详情 |
详情
|
(VII) |
12294 |
Aniline; Phenylamine
|
62-53-3 |
C6H7N |
详情 | 详情
|
合成路线4
该中间体在本合成路线中的序号:
(VIII) The reduction of 1-(1-piperdinyl)acetone oxime (I) with LiAlH4 in ethyl ether, THF or dioxan gives 1-methyl2-(1-piperidinyl)ethylaine (II), which is acylated with propionyl chloride (III) in ether to afford propionamide (IV). The condensation of (IV) with 2-bromopyridine (V) by heating with K2CO3 and Cu (dust) provides compound (VI). Alternatively, (VI) can be obtained by heating N-[1-methyl-2-(1-piperidinyl)ethyl]-N-(2-pyridyl)amine (VII) with propionic anhydride (VIII). Finally, heating derivative (VI) with fumaric acid in acetone/EtOH allows formation of the desired compound as the corresponding fumarate salt.

【1】
(Almirall Prodesfarma, SA); Process for the preparation of 2-aminopyridine derivs.. ES 434325 .
|
【2】
Hoffmeister, F.; Wirth, W.; Kroneberg, H.-G.; Hiltmann, R.; Wollweber, H. (Bayer AG); Pyridine derivs. and their preparation (-N-tertiaryl aminoalkyl-N-acyl)amino pyridines. DE 1232147; US 3163654 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
47242 |
1-(1-piperidinyl)acetone oxime
|
|
C8H16N2O |
详情 |
详情
|
(II) |
47243 |
1-methyl-2-(1-piperidinyl)ethylamine; 1-(1-piperidinyl)-2-propanamine
|
|
C8H18N2 |
详情 |
详情
|
(III) |
15967 |
propanoyl chloride; propionyl chloride
|
79-03-8 |
C3H5ClO |
详情 | 详情
|
(IV) |
47244 |
N-[1-methyl-2-(1-piperidinyl)ethyl]propanamide
|
|
C11H22N2O |
详情 |
详情
|
(V) |
29052 |
2-Bromopyridine;α-bromopyridine;α-bromoazine |
109-04-6 |
C5H4BrN |
详情 | 详情
|
(VI) |
47245 |
N-[1-methyl-2-(1-piperidinyl)ethyl]-N-(2-pyridinyl)propanamide
|
|
C16H25N3O |
详情 |
详情
|
(VII) |
47246 |
N-[1-methyl-2-(1-piperidinyl)ethyl]-2-pyridinamine; N-[1-methyl-2-(1-piperidinyl)ethyl]-N-(2-pyridinyl)amine
|
|
C13H21N3 |
详情 |
详情
|
(VIII) |
20095 |
propionic anhydride
|
123-62-6 |
C6H10O3 |
详情 | 详情
|
合成路线5
该中间体在本合成路线中的序号:
(A) The esterification of 1-benzyl-4-(phenylamino)piperidine-4-carboxylic acid (I) with ethanol and H2SO4 gives the corresponding ethyl ester (II), which is reduced with LiAlH2(OCH2CH2OCH3)2 in benzene affording 1-benzyl-4-(phenylamino)piperidine-4-methanol (III) The methylation of (III) with methyl iodide and NaH in HMPA yields 1-benzyl-4-methoxymethyl-4-(phenylamino)piperidine (IV), which is refluxed with propionic anhydride (A) to give N-[4-(methoxymethyl)-1-benzyl-4-piperidyl]propionanilide (V). The hydrogenolysis of (V) with H2 over Raney-Ni in methanol yields N-[4-(methoxymethyl)-4-piperidyl]propionanilide (VI), which is finally condensed with 2-thiopheneethanol methanesulfonate (B) by means of Na2CO3 in methyl isobutyl ketone.

【1】
Van Daele, P.G.H.; et al.; Synthetic analgesics: N-(1-[2-arylethyl]-4-substituted-4-piperidinyl)-N-arylalkanamides. Arzneim-Forsch Drug Res 1976, 26, 8, 1521.
|
【2】
Castaner, J.; Arrigoni-Martelli, E.; Sufentanil. Drugs Fut 1977, 2, 5, 334.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(A) |
20095 |
propionic anhydride
|
123-62-6 |
C6H10O3 |
详情 | 详情
|
(B) |
33889 |
2-(2-thienyl)-1-ethanol; Thiophene-2-ethanol
|
5402-55-1 |
C6H8OS |
详情 | 详情
|
(I) |
33884 |
4-anilino-1-benzyl-4-piperidinecarboxylic acid
|
|
C19H22N2O2 |
详情 |
详情
|
(II) |
33885 |
ethyl 4-anilino-1-benzyl-4-piperidinecarboxylate
|
|
C21H26N2O2 |
详情 |
详情
|
(III) |
33886 |
(4-anilino-1-benzyl-4-piperidinyl)methanol
|
|
C19H24N2O |
详情 |
详情
|
(IV) |
33887 |
N-[1-benzyl-4-(methoxymethyl)-4-piperidinyl]-N-phenylamine; 1-benzyl-4-(methoxymethyl)-N-phenyl-4-piperidinamine
|
|
C20H26N2O |
详情 |
详情
|
(V) |
33888 |
N-[1-benzyl-4-(methoxymethyl)-4-piperidinyl]-N-phenylpropanamide
|
|
C23H30N2O2 |
详情 |
详情
|
(VI) |
32220 |
N-[4-(methoxymethyl)-4-piperidinyl]-N-phenylpropanamide
|
|
C16H24N2O2 |
详情 |
详情
|
合成路线6
该中间体在本合成路线中的序号:
The dehydrogenation of 16alpha-methyl-11beta,17alpha,21-trihydroxypregna-1,4-diene-3,20-dione-21-acetate (I) with dichlorodicyanobenzoquinone (II) in dioxane HCl gives 16alpha-methyl-11beta,17alpha,21-trihydroxypregna-1,4,6-triene-3,20-dione-21-acetate (III), which is hydrolyzed with aqueous NaHCO3 to the corresponding free triol (IV). The reaction of (IV) with triethyl orthopropionate (A) by means of p-toluenesulfonic acid in DMSO yields 16alpha-methyl-11beta,17alpha,21-trihydroxypregna-1,4,6-triene-3,20-dione-17,21-ethylorthopropionate (V), which is hydrolyzed partially with acetic acid to 16alpha-methyl-11beta,17alpha,21-trihydroxypregna-1,4,6-triene-3,20-dione-17-propionate (VI). The acylation of (VI) with propionic anhydride affords 16alpha-methyl-11beta,17alpha,21-trihydroxypregna-1,4,6-triene-3,20-dione-17,21-dipropionate (VII), which is finally treated with dry HCl in dioxane.

【1】
Green, M.J.; et al. (Schering Corp.); 7alpha-Halogeno-3,20-dioxo-1,4-pregnadienes, methods for their manufacture, their use as anti-inflammatory agents, and pharmaceutical formulations useful therefor. US 4124707 .
|
【2】
Green, M.J.; et al. (Schering Corp.); Process for the preparation of 7{60 -halogeno-3-oxo-4-dehydro steroids and novel 7{60 -halogeno derivatives produced thereby. CA 1099254; US 4076708 .
|
【3】
Van Wagenen, B.C.; Barmore, R.M. (NPS Pharmaceuticals, Inc.); Chiral reductions of imines leading to the syntheses of optically active amines. WO 9711934 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
20095 |
propionic anhydride
|
123-62-6 |
C6H10O3 |
详情 | 详情
|
(A) |
10395 |
1,1,1-Triethoxypropane; 1,1-Diethoxypropyl ethyl ether; Triethyl orthopropionate
|
115-80-0 |
C9H20O3 |
详情 | 详情
|
(I) |
32645 |
2-[(8S,9S,10R,11S,13S,14S,16R,17R)-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl acetate
|
|
C24H32O6 |
详情 |
详情
|
(II) |
21890 |
2,3-dichloro-5,6-dicyano-1,4-benzoquinone; 4,5-dichloro-3,6-dioxo-1,4-cyclohexadiene-1,2-dicarbonitrile
|
84-58-2 |
C8Cl2N2O2 |
详情 | 详情
|
(III) |
32646 |
2-[(8S,9S,10R,11S,13S,14S,16R,17R)-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-8,9,10,11,12,13,14,15,16,17-decahydro-3H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl acetate
|
13796-64-0 |
C24H30O6 |
详情 | 详情
|
(IV) |
32647 |
(8S,9S,10R,11S,13S,14S,16R,17R)-17-glycoloyl-11,17-dihydroxy-10,13,16-trimethyl-8,9,10,11,12,13,14,15,16,17-decahydro-3H-cyclopenta[a]phenanthren-3-one
|
13954-10-4 |
C22H28O5 |
详情 | 详情
|
(V) |
32648 |
2'-Ethoxy-2'-ethyl-11beta-hydroxy-16alpha-methylspiro[androsta-1,4,6-triene-17(R),4'-[1,3]dioxane]-3,5'-dione
|
67212-72-0 |
C27H36O6 |
详情 | 详情
|
(VI) |
32649 |
(8S,9S,10R,11S,13S,14S,16R,17R)-17-glycoloyl-11-hydroxy-10,13,16-trimethyl-3-oxo-8,9,10,11,12,13,14,15,16,17-decahydro-3H-cyclopenta[a]phenanthren-17-yl propionate
|
|
C25H32O6 |
详情 |
详情
|
(VII) |
32650 |
(8S,9S,10R,11S,13S,14S,16R,17R)-11-hydroxy-10,13,16-trimethyl-3-oxo-17-[2-(propionyloxy)acetyl]-8,9,10,11,12,13,14,15,16,17-decahydro-3H-cyclopenta[a]phenanthren-17-yl propionate
|
67212-74-2 |
C28H36O7 |
详情 | 详情
|
合成路线7
该中间体在本合成路线中的序号:
The dehydrogenation of 16alpha-methyl-17alpha,21-dihydroxypregna-1,4-diene-3,11,20-trione-21-acetate (VIII) with (II) in dioxane-HCl gives 16alpha-methyl-17alpha,21-dihydroxypregna-1,4,6-triene-3,11,20-trione-21-acetate (IX), which is hydrolyzed with aqueous NaHCO3 to the corresponding free diol (X). The reaction of (X) with triethyl orthopropionate (A) as before yields 16alpha-methyl-17alpha,21-dihydroxypregna-1,4,6-triene-3,11,20-trione-17,21-ethylorthopropionate (XI), which is hydrolyzed partially with acetic acid to 16alpha-methyl-17alpha,21-dihydroxypregna-1,4,6-triene-3,11,20-trione-17-propionate (XII). The acylation of (XII) with propionic anhydride yields the corresponding dipropionate (XIII), which is treated with dry HCl in dioxane to afford 16alpha-methyl-17alpha,21-dihydroxy-7alpha-chloropregna-1,4-diene-3,11,20-trione 17,21-dipropionate (XIV). Finally, this compound is reduced with NaSH4 in methanol - THF.

【1】
Green, M.J.; et al. (Schering Corp.); 7alpha-Halogeno-3,20-dioxo-1,4-pregnadienes, methods for their manufacture, their use as anti-inflammatory agents, and pharmaceutical formulations useful therefor. US 4124707 .
|
【2】
Green, M.J.; et al. (Schering Corp.); Process for the preparation of 7{60 -halogeno-3-oxo-4-dehydro steroids and novel 7{60 -halogeno derivatives produced thereby. CA 1099254; US 4076708 .
|
【3】
Van Wagenen, B.C.; Barmore, R.M. (NPS Pharmaceuticals, Inc.); Chiral reductions of imines leading to the syntheses of optically active amines. WO 9711934 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
20095 |
propionic anhydride
|
123-62-6 |
C6H10O3 |
详情 | 详情
|
(A) |
10395 |
1,1,1-Triethoxypropane; 1,1-Diethoxypropyl ethyl ether; Triethyl orthopropionate
|
115-80-0 |
C9H20O3 |
详情 | 详情
|
(II) |
21890 |
2,3-dichloro-5,6-dicyano-1,4-benzoquinone; 4,5-dichloro-3,6-dioxo-1,4-cyclohexadiene-1,2-dicarbonitrile
|
84-58-2 |
C8Cl2N2O2 |
详情 | 详情
|
(VIII) |
32651 |
2-[(8S,9S,10R,13S,14S,16R,17R)-17-hydroxy-10,13,16-trimethyl-3,11-dioxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl acetate
|
|
C24H30O6 |
详情 |
详情
|
(IX) |
32652 |
2-[(8S,9S,10R,13S,14S,16R,17R)-17-hydroxy-10,13,16-trimethyl-3,11-dioxo-8,9,10,11,12,13,14,15,16,17-decahydro-3H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl acetate
|
|
C24H28O6 |
详情 |
详情
|
(X) |
32653 |
(8S,9S,10R,13S,14S,16R,17R)-17-glycoloyl-17-hydroxy-10,13,16-trimethyl-9,10,12,13,14,15,16,17-octahydro-3H-cyclopenta[a]phenanthrene-3,11(8H)-dione
|
|
C22H26O5 |
详情 |
详情
|
(XI) |
32654 |
2'-Ethoxy-2'-ethyl-16alpha-methylspiro[androsta-1,4,6-triene-17(R),4'-[1,3]dioxane]-3,5',11-trione
|
|
C27H34O6 |
详情 |
详情
|
(XII) |
32655 |
(8S,9S,10R,13S,14S,16R,17R)-17-glycoloyl-10,13,16-trimethyl-3,11-dioxo-8,9,10,11,12,13,14,15,16,17-decahydro-3H-cyclopenta[a]phenanthren-17-yl propionate
|
|
C25H30O6 |
详情 |
详情
|
(XIII) |
32656 |
2-oxo-2-[(8S,9S,10R,13S,14S,16R,17R)-10,13,16-trimethyl-3,11-dioxo-17-(propionyloxy)-8,9,10,11,12,13,14,15,16,17-decahydro-3H-cyclopenta[a]phenanthren-17-yl]ethyl propionate
|
|
C28H34O7 |
详情 |
详情
|
(XIV) |
32657 |
(7R,8S,9S,10R,13S,14S,16R,17R)-7-chloro-10,13,16-trimethyl-3,11-dioxo-17-[2-(propionyloxy)acetyl]-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl propionate
|
|
C28H35ClO7 |
详情 |
详情
|
合成路线8
该中间体在本合成路线中的序号:
(II) The acylation of benzoxazolin-2-one (I) with propionic anhydride (II) by means of P2O5 and MsOH gives 6-propionylbenzoxazolin-2-one (III), which is treated with chloroacetyl chloride to yield 7-propionyl-3,4-dihydro-2H-1,4-benzoxazin-3-one (IV). The Mannich condensation of (IV) with CH2O and NH3 followed by methylation with methyl iodide affords the trimethylammonium compound (V), which by reaction with KCN, followed by hydrolysis with HCl gives 3-(3-oxo-3,4-dihydro-2H-1,4-benzoxazin-7-ylcarbonyl)butyric acid (VI). Finally this compound is cyclized with hydrazine to furnish the target pyridazinone.

【1】
Bonte, J.P.; Lesier, D.; Lespagnol, C.; et al.; 6-Acyl benzoxazolinones. I. Eur J Med Chem - Chim Ther 1974, 9, 491.
|
【2】
Kryvenko, M.; Techer, H.; Lavergne, M.; et al.; Electrophilic substitutions of 2H-1,4-benzoxazine-3-one: Acylation and chlorosulfonation. CR Acad Sci Paris Ser C 1970, 270, 19, 1601.
|
【3】
Lesier, D.; Lespagnol, C.; Bonte, J.P.; et al.; 6-Acyl benzoxazolinones. II. Preparation of some transformation products. Eur J Med Chem - Chim Ther 1974, 9, 497-500.
|
【4】
Thyes, M.; Lehmann, H.D.; Gries, J.; et al.; 6-Aryl-4,5-dihydro-3(2H)-pyridazinones. A new class of compounds with platelet aggregation inhibiting and hypotensive activities. J Med Chem 1983, 26, 6, 800.
|
【5】
Moussavi, Z.; Lesieur, D.; Depreux, P.; An aternative synthesis of cardiotonic 6-(3,4-dihydro-3-oxo-1,4[2H]benzoxazin-7-yl)-2,3,4,5-tetrahydro-5-methylpyridazin-3-ones. Synth Commun 1991, 21, 2, 271.
|
【6】
Combs, D.W.; Bemoradan and related pyridazinone cardiotonics. Drugs Fut 1993, 18, 2, 139.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(A) |
11296 |
2-Chloroacetyl chloride; Chloroacetic chloride
|
79-04-9 |
C2H2Cl2O |
详情 | 详情
|
(I) |
41299 |
2-Benzoxazolinone; 2(3H)-benzoxazolone; 1,3-benzoxazol-2(3H)-one
|
59-49-4 |
C7H5NO2 |
详情 | 详情
|
(II) |
20095 |
propionic anhydride
|
123-62-6 |
C6H10O3 |
详情 | 详情
|
(III) |
41300 |
6-propionyl-1,3-benzoxazol-2(3H)-one
|
|
C10H9NO3 |
详情 |
详情
|
(IV) |
41301 |
7-propionyl-2H-1,4-benzoxazin-3(4H)-one
|
|
C11H11NO3 |
详情 |
详情
|
(V) |
41302 |
N,N,N,2-tetramethyl-3-oxo-3-(3-oxo-3,4-dihydro-2H-1,4-benzoxazin-7-yl)-1-propanaminium
|
|
C15H21N2O3 |
详情 |
详情
|
(VI) |
41303 |
3-methyl-4-oxo-4-(3-oxo-3,4-dihydro-2H-1,4-benzoxazin-7-yl)butyric acid
|
|
C13H13NO5 |
详情 |
详情
|
合成路线9
该中间体在本合成路线中的序号:
(VII) The reaction of 1-benzyl-4-piperidone (I) with aniline (II) and KCN in acetic acid gives the aminonitrile (III), which is treated with H2SO4 at room temperature to yield the carboxamide (IV). The hydrolysis of (IV) with refluxing aqueous HCl affords the carboxylic acid (V), which is esterified with Ms-OH and methanol to provide the methyl ester (VI). Acylation of the NH group of (VI) with propionic anhydride (VII) gives the propionamide (VIII), which is debenzylated with H2 over Pd/C to yield the piperidine (IX). Finally, this compound is condensed with methyl acrylate (XI) in acetonitrile to afford the target compound.

【1】
Killgore, J.K.; Jacob, M. (Mallinckrodt Medical Inc.); New methods for the syntheses of alfentanil, sufentanil and remifentanil. WO 0140184 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
15720 |
1-benzyltetrahydro-4(1H)-pyridinone; 1-Benzyl-4-piperidone; N-Benzyl-4-piperidone; 1-(benzyl)-4-piperidinone; 1-benzylpiperidin-4-one; 1-(benzyl)piperidin-4-one
|
3612-20-2 |
C12H15NO |
详情 | 详情
|
(II) |
12294 |
Aniline; Phenylamine
|
62-53-3 |
C6H7N |
详情 | 详情
|
(III) |
49674 |
4-Anilino-1-benzyl-4-cyanopiperidine
|
|
C19H21N3 |
详情 |
详情
|
(IV) |
49675 |
4-Anilino-1-benzylisonipecotamide
|
|
C19H23N3O |
详情 |
详情
|
(V) |
33884 |
4-anilino-1-benzyl-4-piperidinecarboxylic acid
|
|
C19H22N2O2 |
详情 |
详情
|
(VI) |
49676 |
methyl 4-anilino-1-benzyl-4-piperidinecarboxylate
|
|
C20H24N2O2 |
详情 |
详情
|
(VII) |
20095 |
propionic anhydride
|
123-62-6 |
C6H10O3 |
详情 | 详情
|
(VIII) |
49677 |
methyl 1-benzyl-4-(propionylanilino)-4-piperidinecarboxylate
|
|
C23H28N2O3 |
详情 |
详情
|
(IX) |
15668 |
methyl 4-(propionylanilino)-4-piperidinecarboxylate
|
|
C16H22N2O3 |
详情 |
详情
|
(X) |
14156 |
methyl acrylate
|
96-33-3 |
C4H6O2 |
详情 | 详情
|
合成路线10
该中间体在本合成路线中的序号:
(II) An improved synthesis of 5,7-dihydroxy-8-propionyl-4-propyl-2H-1-benzopyran-2-one, a key intermediate in the synthesis of (+)-calanolide A, has been reported: Friedel-Crafts acylation of 5,7-dihydroxy-4-propyl-2H-1-benzopyran-2-one (I) with propionic anhydride (II) by means of AlCl3 in refluxing nitromethane.

【1】
Xu, Z.-Q.; Zembower, D.E.; Flavin, M.T.; Jimenez, N.; Kirchhoff, E.W.; Zhang, J.; Sen, P.; Automated process research. An example of accelerated optimization of the friedel-grafts acylation reaction, a key step for the synthesis of anti-HIV (+)-calanolide A. Org Process Res Dev 2000, 4, 6, 577. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
22405 |
5,7-dihydroxy-4-propyl-2H-chromen-2-one
|
|
C12H12O4 |
详情 |
详情
|
(II) |
20095 |
propionic anhydride
|
123-62-6 |
C6H10O3 |
详情 | 详情
|
(III) |
22407 |
5,7-dihydroxy-8-propionyl-4-propyl-2H-chromen-2-one
|
|
C15H16O5 |
详情 |
详情
|
合成路线11
该中间体在本合成路线中的序号:
(II) Condensation of p-fluorobenzaldehyde (I) with propionic anhydride (II) by means of sodium propionate at 140 C affords p-fluoro-alpha-methylcinnamic acid (III), which is then hydrogenated over Pd/C in EtOH to provide p-fluoro-alpha-methylhydrocinnamic acid (IV). Derivative (IV) is subjected to cyclization by treatment with polyphosphoric acid (PPA) to give 6-fluoro-2-methylindanone (V), which is converted into 5-fluoro-2-methylindenyl-3-acetic acid (VII) by first condensation with cyanoacetic acid (VI) by means of acetic acid and ammonium acetate in refluxing toluene, followed by hydrolysis with KOH in hot ethanol. Condensation of derivative (VII) with p-methylthiobenzaldehyde (VIII) by means of sodium methoxide in hot MeOH affords 5-fluoro-2-methyl-1-[p-(methylsulfanyl)benzylidene]-3-indenyl acetic acid (IX), which is then oxidized in MeOH/acetone by means of an aqueous solution of sodium periodate to yield methylsulfinylbenzylidene derivative (X). Finally, the target product is obtained by further oxidation of (X) with H2O2 in the presence of sodium methoxide and sodium bicarbonate in MeOH/acetonitrile at -10 C.

【1】
Mayle, M.J.; Menander, K.B. (Cell Pathways, Inc.); A method for treating patients with acne by administering a cyclic GMP PDE inhibitor. WO 0044372 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
12337 |
4-fluorobenzaldehyde |
459-57-4 |
C7H5FO |
详情 | 详情
|
(II) |
20095 |
propionic anhydride
|
123-62-6 |
C6H10O3 |
详情 | 详情
|
(III) |
48870 |
(Z)-3-(4-fluorophenyl)-2-methyl-2-propenoic acid
|
|
C10H9FO2 |
详情 |
详情
|
(IV) |
48871 |
3-(4-fluorophenyl)-2-methylpropionic acid
|
|
C10H11FO2 |
详情 |
详情
|
(V) |
48872 |
6-Fluoro-2-methylindanone
|
|
C10H9FO |
详情 |
详情
|
(VI) |
12591 |
Cyanoacetic Acid; 2-Cyanoacetic acid
|
372-09-8 |
C3H3NO2 |
详情 | 详情
|
(VII) |
48874 |
2-(5-fluoro-2-methyl-1H-inden-3-yl)acetic acid
|
|
C12H11FO2 |
详情 |
详情
|
(VIII) |
18815 |
4-(methylsulfanyl)benzaldehyde; 4-(methylmercapto)benzaldehyde
|
3446-89-7 |
C8H8OS |
详情 | 详情
|
(IX) |
51940 |
2-(5-fluoro-2-methyl-1-[(E)-[4-(methylsulfanyl)phenyl]methylidene]-1H-inden-3-yl)acetic acid
|
|
C20H17FO2S |
详情 |
详情
|
(X) |
51941 |
2-(5-fluoro-2-methyl-1-[(E)-[4-(methylsulfinyl)phenyl]methylidene]-1H-inden-3-yl)acetic acid
|
|
C20H17FO3S |
详情 |
详情
|
合成路线12
该中间体在本合成路线中的序号:
(II) The acylation of 4-(5-methyl-3-phenylisoxazol-4-yl)benzenesulfonamide, valdecoxib (I), with propionic anhydride (II) by means of TEA and DMAP in THF gives N-[4-(5-methyl-3-phenylisoxazol-4-yl)phenylsulfonyl]propionamide (III), which is then treated with NaOH in ethanol.

【1】
Leeson, P.; Castaner, J.; Castaner, R.M.; Sorbera, L.A.; Valdecoxib and Parecoxib Sodium. Drugs Fut 2001, 26, 2, 133.
|
【2】
Koboldt, C.M.; Talley, J.J.; Seibert, K.; Carter, J.S.; Yuan, J.; Kellog, M.S.; Bertenshaw, S.R.; Brown, D.L.; Zhang, Y.Y.; Graneto, M.J.; N-[[(5-Methyl-3-phenylisoxazol-4-yl)-phenyl]sulfonyl]propanamide, sodium salt, parecoxib sodium: A potent and selective inhibitor of COX-2 for parenteral administration. J Med Chem 2000, 43, 9, 1661. |
【3】
Talley, J.J.; Malecha, J.W.; Bertenshaw, S.; Graneto, M.J.; Carter, J.S.; Li, J.; Nagarajan, S.; Brown, D.L.; Rogier, D.J. Jr.; Penning, T.D.; Khanna, I.K.; Xu, X.; Weier, R.M. (Pharmacia Corp.); Substd. benzenesulfonamide derivs. as prodrugs of COX-2 inhibitors. EP 0892791; JP 2000509029; US 5932598; WO 9738986 . |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
44350 |
4-(5-methyl-3-phenyl-4-isoxazolyl)benzenesulfonamide
|
|
C16H14N2O3S |
详情 |
详情
|
(II) |
20095 |
propionic anhydride
|
123-62-6 |
C6H10O3 |
详情 | 详情
|
(III) |
44351 |
4-(5-methyl-3-phenyl-4-isoxazolyl)-N-propionylbenzenesulfonamide
|
|
C19H18N2O4S |
详情 |
详情
|
合成路线13
该中间体在本合成路线中的序号:
(II) Heating p-fluorobenzaldehyde (I) with propionic anhydride (II) in the presence of sodium propionate affords methyl cinnamic acid derivative (III), which is then hydrogenated over Pd/C in EtOH to provide methyl hydrocinnamic acid derivative (IV). Ring closure of (IV) is then performed by heating with polyphosphoric acid to yield methylindanone derivative (V). Condensation of (V) with cyanoacetic acid (VI) by means of ammonium acetate and HOAc in refluxing toluene, followed by treatment with KOH in refluxing EtOH, provides acetic acid derivative (VII), which is then condensed with 3,4,5-trimethoxybenzaldehyde (VIII) by heating with NaOMe in MeOH to give substituted benzylidene derivative (IX). The target product can be finally obtained either by direct condensation of (IX) with benzylamine (XI) by means of DMAP and EDC in DMA or by first conversion of (IX) into the corresponding acetyl chloride by reaction with oxalyl chloride in refluxing THF, followed by coupling with benzylamine (XI) in CH2Cl2.
Alternatively, the desired compound can also be obtained by coupling of acetic acid derivative (VII) with benzylamine (XI) by means of DMAP, EDC in DMA to afford N-benzyl acetamide derivative (XII), followed by condensation with 3,4,5-trimethoxybenzaldehyde (VIII) by heating with NaOMe in MeOH.

【1】
Sperl, G.; Gross, P.; Brendel, K.; Pamucku, R.; Piazza, G.A. (University of Arizona); Substd. benzylidene indenyl formamides, acetamides and propionamides. WO 9747303 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
12337 |
4-fluorobenzaldehyde |
459-57-4 |
C7H5FO |
详情 | 详情
|
(II) |
20095 |
propionic anhydride
|
123-62-6 |
C6H10O3 |
详情 | 详情
|
(III) |
48870 |
(Z)-3-(4-fluorophenyl)-2-methyl-2-propenoic acid
|
|
C10H9FO2 |
详情 |
详情
|
(IV) |
48871 |
3-(4-fluorophenyl)-2-methylpropionic acid
|
|
C10H11FO2 |
详情 |
详情
|
(V) |
48872 |
6-Fluoro-2-methylindanone
|
|
C10H9FO |
详情 |
详情
|
(VI) |
48873 |
2-Oxopropionitrile; Acetylcyanide; Pyruvonitrile
|
|
C3H3NO |
详情 |
详情
|
(VII) |
48874 |
2-(5-fluoro-2-methyl-1H-inden-3-yl)acetic acid
|
|
C12H11FO2 |
详情 |
详情
|
(VIII) |
11136 |
3,4,5-Trimethoxybenzaldehyde
|
86-81-7 |
C10H12O4 |
详情 | 详情
|
(IX) |
48875 |
2-[5-fluoro-2-methyl-1-[(E)-(3,4,5-trimethoxyphenyl)methylidene]-1H-inden-3-yl]acetic acid
|
|
C22H21FO5 |
详情 |
详情
|
(X) |
48876 |
2-[5-fluoro-2-methyl-1-[(E)-(3,4,5-trimethoxyphenyl)methylidene]-1H-inden-3-yl]acetyl chloride
|
|
C22H20ClFO4 |
详情 |
详情
|
(XI) |
15147 |
Benzylamine; Phenylmethanamine
|
100-46-9 |
C7H9N |
详情 | 详情
|
(XII) |
48877 |
N-benzyl-2-(5-fluoro-2-methyl-1H-inden-3-yl)acetamide
|
|
C19H18FNO |
详情 |
详情
|
合成路线14
该中间体在本合成路线中的序号:
(A) By esBy esterification of camptothecin (I) with propionic anhydride in pyridine.
terification of camptothecin (I) with propionic anhydride in pyridine.

【1】
Cao, Z.; et al.; Alkyl esters of camptothecin and 9-nitrocamptothecin: Synthesis, in vitro pharmacokinetics, toxicity, and antitumor activity. J Med Chem 1998, 41, 1, 31.
|
【2】
Ciovanella, B.C.; Zhisong, C. (The Stehlin Foundation for Cancer Research); Derivs. of camptothecin for use in treating cancer. EP 0879236; WO 9728165 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(A) |
20095 |
propionic anhydride
|
123-62-6 |
C6H10O3 |
详情 | 详情
|
(I) |
25916 |
(4S)-4-hydroxy-4-methyl-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
|
|
C20H16N2O4 |
详情 |
详情
|
合成路线15
该中间体在本合成路线中的序号:
(II) 7-Hydroxy-3-methylcoumarin (III) was obtained by Perkin reaction of 2,4-dihydroxybenzaldehyde (I) and propionic anhydride (II) in the presence of sodium propionate in pyridine. Alkylation of N-phenylpiperazine (IV) with 1-bromo-3-chloropropane (V) and NaOH in acetone provided the chloropropyl compond (VI), which was finally condensed with coumarin (III) using NaH in DMF.

【1】
Antonello, C.; et al.; Synthesis and characterization of new methylpsoralens as potential photochemotherapeutic agents. Farmaco 1994, 49, 4, 277.
|
【2】
Teran, C.; Santana, L.; Uriarte, E.; Fall, Y.; Unelius, L.; Tolf, B.R.; Phenylpiperazine derivatives with strong affinity for 5HT1A, D2A and D3 receptors. Bioorg Med Chem Lett 1998, 8, 24, 3567.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
20094 |
2,4-dihydroxybenzaldehyde
|
95-01-2 |
C7H6O3 |
详情 | 详情
|
(II) |
20095 |
propionic anhydride
|
123-62-6 |
C6H10O3 |
详情 | 详情
|
(III) |
20096 |
7-hydroxy-3-methyl-2H-chromen-2-one
|
|
C10H8O3 |
详情 |
详情
|
(IV) |
10756 |
N-Phenylpiperazine; 1-Phenylpiperazine; Phenyl piperazine
|
92-54-6 |
C10H14N2 |
详情 | 详情
|
(V) |
10358 |
1-Bromo-3-chloropropane
|
109-70-6 |
C3H6BrCl |
详情 | 详情
|
(VI) |
20099 |
1-(3-chloropropyl)-4-phenylpiperazine
|
|
C13H19ClN2 |
详情 |
详情
|
合成路线16
该中间体在本合成路线中的序号:
(II) Heating p-fluorobenzaldehyde (I) with propionic anhydride (II) in the presence of sodium propionate affords methyl cinnamic acid derivative (III), which is then hydrogenated over Pd/C in EtOH to provide methyl hydrocinnamic acid derivative (IV). Ring closure of (IV) is then performed by heating with polyphosphoric acid to yield methylindanone derivative (V). Condensation of (V) with cyanoacetic acid (VI) by means of ammonium acetate and HOAc in refluxing toluene followed by treatment with KOH in refluxing EtOH provides acetic acid derivative (VII), which is then converted into acetyl chloride compound (VIII) by reaction with oxalyl chloride in refluxing THF. Coupling of (VIII) with benzylamine (IX) in refluxing CH2Cl2 gives indenylacetamide derivative (X), which is finally condensed with 4-pyridinecarboxaldehyde (XI) by means of NaOMe in MeOH to furnish the desired compound.

【1】
Piazza, G.; Gross, P.; Brendel, K.; Sperl, G.; Pamukcu, R. (Cell Pathways, Inc.; University of Arizona); N-Benzyl-3-indenylacetamides derivs. for treating neoplasia. EP 1044187; US 5948779; US 6066634; WO 9931065 .
|
【2】
Mayle, M.J.; Menander, K.B. (Cell Pathways, Inc.); A method for treating patients with acne by administering a cyclic GMP PDE inhibitor. WO 0044372 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
12337 |
4-fluorobenzaldehyde |
459-57-4 |
C7H5FO |
详情 | 详情
|
(II) |
20095 |
propionic anhydride
|
123-62-6 |
C6H10O3 |
详情 | 详情
|
(III) |
48870 |
(Z)-3-(4-fluorophenyl)-2-methyl-2-propenoic acid
|
|
C10H9FO2 |
详情 |
详情
|
(IV) |
48871 |
3-(4-fluorophenyl)-2-methylpropionic acid
|
|
C10H11FO2 |
详情 |
详情
|
(V) |
48872 |
6-Fluoro-2-methylindanone
|
|
C10H9FO |
详情 |
详情
|
(VI) |
48873 |
2-Oxopropionitrile; Acetylcyanide; Pyruvonitrile
|
|
C3H3NO |
详情 |
详情
|
(VII) |
48874 |
2-(5-fluoro-2-methyl-1H-inden-3-yl)acetic acid
|
|
C12H11FO2 |
详情 |
详情
|
(VIII) |
48878 |
2-(5-fluoro-2-methyl-1H-inden-3-yl)acetyl chloride
|
|
C12H10ClFO |
详情 |
详情
|
(IX) |
15147 |
Benzylamine; Phenylmethanamine
|
100-46-9 |
C7H9N |
详情 | 详情
|
(X) |
48877 |
N-benzyl-2-(5-fluoro-2-methyl-1H-inden-3-yl)acetamide
|
|
C19H18FNO |
详情 |
详情
|
(XI) |
17203 |
4-Pyridinecarboxaldehyde; isonicotinaldehyde
|
872-85-5 |
C6H5NO |
详情 | 详情
|
合成路线17
该中间体在本合成路线中的序号:
(XIV) The precursor 4-bromo-2,6-diethylpyridine (V) can be prepared by several methods. Condensation of 3-oxoglutaric acid (XIII) with propionic anhydride (XIV) in the presence of H2SO4, followed by cyclization with HCl at 100 °C leads to 2,6-diethyl-4-pyranone (XV). Subsequent treatment of pyranone (XV) with NH4OH at 50 °C yields 2,6-diethyl-4-pyridinol (XVI) , which is finally brominated with PBr5 in CHCl3 or POBr3 in DMF at 120 °C .
Alternatively, substitution of 2,6-dichloropyridine (XVII) with ethylmagnesium bromide (XVIII) in the presence of NiCl2(dppp) in Et2O gives 2,6-diethylpyridine (XIX), which can also be obtained by Wolff- Kishner reduction of 2,6-diacetylpyridine (XX) with NH2NH2 in the presence of NaOH in diethylene glycol at 120 °C. Oxidation of 2,6-diethylpyridine (XIX) with mCPBA in CHCl3, followed by nitration of the resulting 2,6-diethylpyridine-1-oxide (XXI) with HNO3 and H2SO4 at 90 °C provides the 4-nitro derivative (XXII). Substitution of nitropyridine (XXII) using AcBr in AcOH at 90 °C affords 4-bromo-2,6-diethylpyridin-1-oxide (XXIII), which is finally reduced with PBr3 in CH2Cl2 .

【1】
Gonzalez, J., Jewell, T.M., Li, H., Linton, A., Tatlock, J.H. (Pfizer, Inc.; Agouron Pharmaceuticals, Inc.). Inhibitors of hepatitis C virus RNAdependent RNA polymerase, and compositions and treatments using the same. EP 1781662, JP 2008509984, US 2006122399, US 7151105, US 8268835, WO 2006018725. |
【2】
Li, H., Tatlock, J., Linton, A. et al. Discovery of (R)-6-cyclopentyl-6-(2-(2,6-diethylpyridin-4-yl)ethyl)-3-((5,7-dimethyl-(1,2,4)triazolo(1,5-a)pyrimidin-2-yl)methyl)-4-hydroxy-5,6-dihydropyran-2-one (PF-00868554) as a potent and orally available hepatitis C virus polymerase inhibitor. J Med Chem 2009, 52(5): 1255-8. |
【3】
Johnson, S., Drowns, M., Tatlock, J. et al. Synthetic route optimization of PF-00868554, an HCV polymerase inhibitor in clinical evaluation. Synlett 2010(5): 796-800. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(V) |
68333 |
4-bromo-2,6-diethylpyridine |
877133-54-5 |
C9H12BrN |
详情 | 详情
|
(XIII) |
15530 |
1,3-Acetonedicarboxylic Acid; 3-Oxopentanedioic acid;3-oxoglutaric acid |
542-05-2 |
C5H6O5 |
详情 | 详情
|
(XIV) |
20095 |
propionic anhydride
|
123-62-6 |
C6H10O3 |
详情 | 详情
|
(XV) |
68342 |
2,6-diethyl-4H-pyran-4-one |
|
C9H12O2 |
详情 | 详情
|
(XVI) |
68343 |
2,6-diethyl-4-pyridinol;2,6-diethylpyridin-4-ol |
|
C9H13NO |
详情 | 详情
|
(XVII) |
13573 |
2,6-Dichloropyridine
|
2402-78-0 |
C5H3Cl2N |
详情 | 详情
|
(XVIII) |
24239 |
bromo(ethyl)magnesium;ethylmagnesium bromide |
925-90-6 |
C2H5BrMg |
详情 | 详情
|
(XIX) |
68344 |
2,6-diethylpyridine |
935-28-4 |
C9H13N |
详情 | 详情
|
(XX) |
48515 |
2,6-Diacetylpyridine
|
1129-30-2 |
C9H9NO2 |
详情 | 详情
|
(XXI) |
68345 |
2,6-diethylpyridine-1-oxide |
|
C9H13NO |
详情 | 详情
|
(XXII) |
68346 |
2,6-diethyl-4-nitropyridine 1-oxide |
|
C9H12N2O3 |
详情 | 详情
|
(XXIII) |
68347 |
4-bromo-2,6-diethylpyridin-1-oxide |
|
C9H12BrNO |
详情 | 详情
|